ISRG vs WST — Key Metrics
| Metric | ISRG (INTUITIVE SURGICAL INC) | WST (WEST PHARMACEUTICAL SERVICES INC) |
|---|---|---|
| Price | 406.63 | 370.76 |
| Market Cap | 143.65 Billion | 26.09 Billion |
| P/E (TTM) | 46.05 | 47.11 |
| P/B (Quarterly) | 6.807 | 8.366 |
| P/S (TTM) | 13.02 | 7.84 |
| Net Profit Margin (TTM) | 28.4 | 17.0 |
| Gross Margin (TTM) | 66.7 | 36.8 |
| ROE (TTM) | 17.8 | 18.5 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ISRG · INTUITIVE SURGICAL INC
Outperform
WST · WEST PHARMACEUTICAL SERVICES INC
Greatly Underperform
Recommendation Summary
Stock ISRG is projected to outperform the market, stock WST is projected to greatly underperform the market. Upfront Recommendation: ISRG.
Financial Metrics
Prices delayed ~15 min
| ISRG | Metrics | WST |
|---|---|---|
| $406.63 | Price | $370.76 |
| — | Market Capitalization | — |
| 46.05 | Price to Earnings Ratio | 47.11 |
| 13.02 | Price to Sales | 7.84 |
| 43.95 | Price to FCF Ratio | 59.72 |
| 19.52 | Price to Gross Profit | 21.32 |
| 101.54 | Price to R&D | 350.71 |
| 15.05 | Price to Current Assets | 14.44 |